Yarui Ma

机构：Chinese Academy of Medical Sciences & Peking Union Medical College

发表论文 15 篇 · 总被引 485 次 · h-index 9

代表论文

• FDX1 can Impact the Prognosis and Mediate the Metabolism of Lung Adenocarcinoma (2021 · Frontiers in Pharmacology · 被引 212)
• AHR mediates the aflatoxin B1 toxicity associated with hepatocellular carcinoma (2021 · Signal Transduction and Targeted Therapy · 被引 126)
• An m6A-Related Prognostic Biomarker Associated With the Hepatocellular Carcinoma Immune Microenvironment (2021 · Frontiers in Pharmacology · 被引 29)
• A CRISPR knockout negative screen reveals synergy between CDKs inhibitor and metformin in the treatment of human cancer in vitro and in vivo (2020 · Signal Transduction and Targeted Therapy · 被引 22)
• Synthetic lethal screening identifies DHODH as a target for MEN1-mutated tumor cells (2022 · Cell Research · 被引 20)
• Methylation silencing of TGF-β receptor type II is involved in malignant transformation of esophageal squamous cell carcinoma (2020 · Clinical Epigenetics · 被引 20)